$ACMR

Wang David H sold $901K of ACMR

Wang David H (See Remarks) sold 9,925 shares of ACM Research, Inc. (ACMR) at $90.78 ($0.90M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not include new company fundamentals (no guidance, deal, or regulatory action).

02

Market read

Primarily sentiment/positioning information; likely limited trading impact absent other catalysts.

03

What to watch

Traders may overreact to insider sales; the key is whether there are concurrent news catalysts (earnings, guidance, contracts) not present in this filing.

Relevance 6/10Novelty 3/10Timing: Filed after-hours/late day (2026-06-05), reflecting a 2026-06-03 sale.

Background

SEC Form 4 insider transaction: officer/director/10% owner reports an open-market sale; 10b5-1 indicates pre-arranged trading rules.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider David H. Wang sold $900,991 of ACMR shares via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Modest, short-lived negative-to-neutral drift possible; no clear directional catalyst from the filing alone.

Evidence & confidence

The transaction is an open-market sale under a pre-arranged 10b5-1 plan, which typically reduces interpretability as a new bearish view.

Market effects

No direct sector read-through; this is company-specific insider activity without new operational/regulatory information.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may be routine liquidity rather than a bearish signal; price impact may be limited.

Key entities

  • ACM Research, Inc.

    Subject of the insider sale disclosure on SEC Form 4.

  • David H. Wang

    Officer/director/10% owner who sold 9,925 shares at $90.7800 on 2026-06-03.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.